U.S. Blood-based Biomarker For Alzheimer’s Disease Diagnostics Market (2025 - 2033) Size, Share & Trends Analysis By Type (Amyloid-related Markers, Tau-related markers, Neurodegeneration), By Technology, By End Use, And Segment Forecasts

Market Segmentation

U.S. Blood-based Biomarker for Alzheimer’s Disease Diagnostics Type Outlook (USD Million; 2021 - 2033)
- Amyloid-related markers
- Tau-related markers
- Neurodegeneration
- Others
U.S. Blood-based Biomarker for Alzheimer’s Disease Diagnostics Technology Outlook (USD Million; 2021 - 2033)
- Immunoassays
- Mass spectrometry-based assays
- Next-generation platforms
- Others
U.S. Blood-based Biomarker for Alzheimer’s Disease Diagnostics End Use Outlook (USD Million; 2021 - 2033)
- Clinical laboratories & hospital labs
- Pharma & biotech
- Academic & research institutes
- Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments